Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Share-based Compensation (2016 - 2026)

Protara Therapeutics' Share-based Compensation history spans 14 years, with the latest figure at $950000.0 for Q1 2026.

  • Quarterly Share-based Compensation rose 48.21% to $950000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Mar 2026, up 11.38% year-over-year, with the annual reading at $3.8 million for FY2025, 7.25% down from the prior year.
  • Share-based Compensation came in at $950000.0 for Q1 2026, down from $1.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $1.9 million in Q2 2022 to a low of $641000.0 in Q1 2025.
  • The 5-year median for Share-based Compensation is $1.2 million (2024), against an average of $1.3 million.
  • Year-over-year, Share-based Compensation tumbled 47.72% in 2025 and then surged 48.21% in 2026.
  • Protara Therapeutics' Share-based Compensation stood at $1.4 million in 2022, then rose by 1.54% to $1.5 million in 2023, then plummeted by 37.74% to $904000.0 in 2024, then increased by 15.38% to $1.0 million in 2025, then decreased by 8.92% to $950000.0 in 2026.
  • Per Business Quant, the three most recent readings for TARA's Share-based Compensation are $950000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025).